Search

everythinglearnresearchcommunity

for

Search:↓

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

New treatments for lupus show promise, but more research is needed, especially for children.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Nilotinib can cause skin issues like red bumps and hair loss.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Alopecia can be a symptom of Neonatal Lupus.

Early detection and aggressive treatment of severe lung complications in lupus are crucial to improve survival.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.

Erlotinib can cause nonscarring hair loss and itchy skin.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Removing the liver tumor improved the patient's skin condition and hair growth.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Careful management of blood thinners is crucial for lupus patients with APS.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.